GlassScriptPhysician profile
Misty A Sawyer
NPI 1225189434
$2,224.80
in general payments reported to CMS, 2019-2025
29 companies · $593 in 2025
The $593 reported for 2025 was more than what 89% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $301 · 2023: $762 · 2024: $569 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,830 · Education: $93.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,830.13 |
| Education | $93.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $314.22 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $248.71 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $241.54 | 2024-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $169.49 | 2022-2025 | Slynd |
| Abbvie INC. | $132.28 | 2022-2023 | |
| Daiichi Sankyo INC. | $105.88 | 2023-2025 | Injectafer |
| Pfizer INC. | $105.13 | 2023-2024 | |
| Agile Therapeutics, INC. | $88.93 | 2022-2023 | Twirla |
| Organon LLC | $88.29 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $84.14 | 2022-2023 | |
| Novo Nordisk INC | $83.07 | 2023-2024 | |
| Mayne Pharma Commercial LLC | $75.06 | 2025 | |
| Dexcom, INC. | $62.85 | 2023-2024 | Dexcom G6 Transmitter |
| Sage Therapeutics, LLC | $54.96 | 2024-2025 | Zurzuvae |
| Boston Scientific Corporation | $47.26 | 2023 | Rezum Generator, Wavewriter Alpha Prime 16 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $46.19 | 2023 | Ligasure |
| Biohaven Pharmaceutical Holding Company LTD. | $36.95 | 2022 | |
| Dynavax Technologies Corporation | $32.38 | 2025 | Heplisav-B |
| Amgen INC. | $27.92 | 2022 | |
| Mylan Pharmaceuticals INC. | $22.91 | 2022 | |
| Inari Medical, INC. | $22.08 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Optumhealth Care Solutions, LLC | $20.25 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coopersurgical, INC. | $19.73 | 2025 | Paragard T 380a |
| Shield Therapeutics INC | $17.84 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $16.15 | 2022 | |
| Therapeuticsmd, INC. | $15.57 | 2022 | |
| Aspira Women'S Health INC | $15.48 | 2023 | Ova1 |
| Merck Sharp & Dohme LLC | $15.13 | 2024 | Gardasil 9, Gardasil |
| Supernus Pharmaceuticals, INC. | $14.41 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misty Sawyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.